Published in J Neurol Neurosurg Psychiatry on July 09, 2013
Coupled changes in brain white matter microstructure and fluid intelligence in later life. J Neurosci (2015) 0.86
Early neuropsychological detection of Alzheimer's disease. Eur J Clin Nutr (2014) 0.83
Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study. PLoS One (2015) 0.81
Exploring anterograde memory: a volumetric MRI study in patients with mild cognitive impairment. Alzheimers Res Ther (2016) 0.77
Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms. Brain Cogn (2016) 0.75
COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. PLoS One (2016) 0.75
Measuring decline in prodromal AD: a pike to hike. J Neurol Neurosurg Psychiatry (2013) 0.75
Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population. Alzheimers Res Ther (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Random-effects models for longitudinal data. Biometrics (1982) 54.17
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
The Set test as an aid to the detection of dementia in old people. Br J Psychiatry (1973) 3.52
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
Mild cognitive impairment in the elderly: predictors of dementia. Neurology (1991) 2.83
The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc (2003) 2.83
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol (2004) 2.29
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain (1991) 2.15
Attentional control in Alzheimer's disease. Brain (2001) 1.97
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci (2010) 1.59
Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol (2006) 1.48
Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord (2006) 1.42
Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med (2000) 1.30
Methodological issues in the study of cognitive decline. Am J Epidemiol (1999) 1.28
Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease. Cortex (2006) 1.17
A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data. Biometrics (2006) 1.12
Gender and education impact on brain aging: a general cognitive factor approach. Psychol Aging (2008) 1.01
Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease. Int J Geriatr Psychiatry (2011) 0.98
Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI). Neuropsychology (2009) 0.96
Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing (1993) 0.95
Designing clinical trials for early (pre-dementia) Alzheimer's disease: determining the appropriate population for treatment. J Nutr Health Aging (2011) 0.90
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Curr Top Behav Neurosci (2012) 0.85
Influence of APOE status on lexical-semantic skills in mild cognitive impairment. J Int Neuropsychol Soc (2011) 0.79
Interest of the new criteria for drug trials in AD. J Nutr Health Aging (2009) 0.79
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology (2003) 6.51
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
Classification criteria for mild cognitive impairment: a population-based validation study. Neurology (2001) 3.92
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42
Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ (2010) 3.37
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol (2001) 2.66
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging (2013) 2.44
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
The mental representation of hand movements after parietal cortex damage. Science (1996) 2.28
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Mild cognitive impairment: conceptual basis and current nosological status. Lancet (2000) 2.19
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci U S A (2001) 2.12
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol (1997) 1.94
Brain networks of spatial awareness: evidence from diffusion tensor imaging tractography. J Neurol Neurosurg Psychiatry (2007) 1.94
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet (1994) 1.85
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 1.85
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol (1994) 1.81
VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study. Neurology (2008) 1.79
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology (2011) 1.72
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry (2003) 1.69
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med (1997) 1.69
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction. J Cogn Neurosci (1998) 1.64
Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol (2007) 1.60
Motor signs predict poor outcomes in Alzheimer disease. Neurology (2005) 1.60
Total hip arthroplasty with use of the Metasul metal-on-metal articulation. Four to seven-year results. J Bone Joint Surg Am (2000) 1.58
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet (1995) 1.55
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia (2002) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology (2011) 1.50
Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry (1984) 1.49
Epileptic electroencephalographic abnormalities and developmental dysphasias: a study of 32 patients. Brain Dev (1992) 1.49
Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology (2011) 1.48
Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47
Ropinirole without levodopa in Parkinson's disease. Lancet (1990) 1.46
Delayed response tasks and prefrontal lesions in man--evidence for self generated patterns of behaviour with poor environmental modulation. Neuropsychologia (1993) 1.45
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol (1996) 1.44
Disability and mild cognitive impairment: a longitudinal population-based study. Int J Geriatr Psychiatry (2001) 1.43
The role of dorsolateral prefrontal cortex in the preparation of forthcoming actions: an fMRI study. Cereb Cortex (2001) 1.42
Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology (2009) 1.41
Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology (2007) 1.41
Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res (2004) 1.41
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol (2000) 1.40
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry (1995) 1.38
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology (1986) 1.35
Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997. Am J Epidemiol (2001) 1.35
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord (1994) 1.32
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry (2005) 1.31
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol (1993) 1.31
Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol (2000) 1.30
Congruent unilateral impairments for real and imagined hand movements. Neuroreport (1995) 1.30
Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology (2011) 1.28
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology (1991) 1.28
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet (1998) 1.27
Somatostatin and dementia in Parkinson's disease. Brain Res (1983) 1.25
Preserved adjustment but impaired awareness in a sensory-motor conflict following prefrontal lesions. J Cogn Neurosci (2001) 1.24
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke (1996) 1.17
TDP-43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.17
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A (2001) 1.17
Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol (1999) 1.16
Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.15
Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke (1996) 1.15
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol (1990) 1.14